CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-16 | Cantley Lewis Clayton Jr. Director | Sale | −1,213 | $59.38 | $72K | 141,789 |
| 2015-11-16 | Cantley Lewis Clayton Jr. Director | Sale | −1,213 | $59.38 | $72K | 141,789 |
| 2015-11-02 | Biller Scott Chief Scientific Officer | Exercise or conversion | +5,500 | $31.64 | $174K | 39,570 |
| 2015-11-02 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $77.12 | $424K | 34,070 |
| 2015-11-02 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 285,380 | ||
| 2015-10-27 | Schenkein David P Chief Executive Officer | Exercise or conversion | +4,000 | $31.64 | $127K | 236,272 |
| 2015-10-27 | Schenkein David P Chief Executive Officer | Sale | −4,000 | $80.26 | $321K | 232,272 |
| 2015-10-27 | Schenkein David P Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −4,000 | 867,320 | ||
| 2015-10-23 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $61.11 | $148K | 143,002 |
| 2015-10-23 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $61.10 | $148K | 143,002 |
| 2015-10-22 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $61.21 | $148K | 145,428 |
| 2015-10-22 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $61.22 | $149K | 145,428 |
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 91,835 |
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +8,843 | $0.30 | $3K | 100,678 |
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +1,157 | $0.47 | $544 | 101,835 |
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Sale | −20,000 | $71.04 | $1.4M | 81,835 |
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 235,022 | ||
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −8,843 | 226,179 | ||
| 2015-10-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −1,157 | 225,022 | ||
| 2015-10-07 | Higgons John Duncan Chief Operating Officer | Gift | −70,000 | 81,835 |
Page 85 of 93 · 1,853 trades